Search

Quick Filters

Compliance Status
Clear

Clinical Trials Data

Showing 542575 of 543136 entries
View as:

The Role of OXytocin in Acute Ischemic Stroke reconvAlesceNcE: The ROXANE Study

Phase: N/A Priority: Normal
NCT ID: NCT05873309 Org: User:
Start: 04/26/23 End: 12/31/24 Due: 12/31/25

A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release (XR) With Respect to Metformin XR Tablet Coadministered With Canagliflozin in Healthy Fed and Fasted Participants

Phase: N/A Priority: Normal
NCT ID: NCT02851095 Org: User:
Start: 08/31/16 End: 11/30/16 Due: 11/30/17

Parent Behavioral Training for Disruptive Behaviors in Tourette Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02882490 Org: User:
Start: 06/30/14 End: 06/30/17 Due: 06/30/18

Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02895503 Org: User:
Start: 01/31/12 End: 08/31/13 Due: 08/31/14

Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform

Phase: N/A Priority: Normal
NCT ID: NCT05520099 Org: User:
Start: 06/26/23 End: 01/31/27 Due: 01/31/28

NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Phase: N/A Priority: Normal
NCT ID: NCT04136184 Org: User:
Start: 12/11/19 End: 07/12/23 Due: 07/12/24

Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00052351 Org: User:
Start: 09/30/02 End: 10/31/07 Due: 10/31/08

Avelumab With Radiotherapy in Patients With Leptomeningeal Disease

Phase: N/A Priority: Normal
NCT ID: NCT03719768 Org: User:
Start: 06/10/19 End: 08/21/24 Due: 08/21/25

Brief Behavioral Therapy for Insomnia(BBTi) in Middle-aged and Older Adults With Chronic Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT06073990 Org: User:
Start: 07/13/23 End: 12/31/25 Due: 12/31/26

Thoracentesis to Alleviate Cardiac Pleural Effusion

Phase: N/A Priority: Normal
NCT ID: NCT05017753 Org: User:
Start: 08/31/21 End: 12/11/24 Due: 12/11/25

Actis Total Hip System 2 Year Follow-up

Phase: N/A Priority: Normal
NCT ID: NCT02783274 Org: User:
Start: 07/01/16 End: 03/13/24 Due: 03/13/25

Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Phase: N/A Priority: Normal
NCT ID: NCT03331198 Org: User:
Start: 11/27/17 End: 11/26/27 Due: 11/26/28

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT04461509 Org: User:
Start: 04/06/21 End: 09/03/24 Due: 09/03/25

24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring

Phase: N/A Priority: Normal
NCT ID: NCT06689696 Org: User:
Start: 02/19/25 End: 02/28/26 Due: 02/28/27

A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)

Phase: N/A Priority: Normal
NCT ID: NCT06052566 Org: User:
Start: 11/21/23 End: 12/05/24 Due: 12/05/25

Evaluation of Copeptin in Patients With Cirrhosis and Ascites

Phase: N/A Priority: Normal
NCT ID: NCT03318601 Org: User:
Start: 05/09/16 End: 03/07/22 Due: 03/07/23

Exparel Versus Bupivacaine in Post-operative Pain Control

Phase: N/A Priority: Normal
NCT ID: NCT06547255 Org: User:
Start: 08/21/24 End: 07/31/25 Due: 07/31/26

Post-marketing Clinical Study of the LAMBRE System for Left Auricle Closure

Phase: N/A Priority: Normal
NCT ID: NCT06465459 Org: User:
Start: 06/10/24 End: 06/10/27 Due: 06/10/28

Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03875287 Org: User:
Start: 04/17/19 End: 12/01/26 Due: 12/01/27

Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients With Hematological Malignancies and Subjected to Treatment With Immune-checkpoint Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT06851702 Org: User:
Start: 06/30/25 End: 12/31/25 Due: 12/31/26

Resiliency Among Older Adults Receiving Lung Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04229381 Org: User:
Start: 01/22/20 End: 06/22/22 Due: 06/22/23

Simulation of Perinatal Grief. (SPG)

Phase: N/A Priority: Normal
NCT ID: NCT06169423 Org: User:
Start: 03/01/23 End: 06/30/23 Due: 06/30/24

Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis

Phase: N/A Priority: Normal
NCT ID: NCT05107934 Org: User:
Start: 12/31/25 End: 10/31/27 Due: 10/31/28

Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients with Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT05861453 Org: User:
Start: 01/10/24 End: 09/30/25 Due: 09/30/26

Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06334692 Org: User:
Start: 03/19/24 End: 03/31/28 Due: 03/31/29